Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway-Reference-Cited by-同舟云学术

Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway

Published:2019-07-08 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ikeda Soichiro,Matsushima Shouji,Okabe Kosuke,Ikeda Masataka,Ishikita Akihito,Tadokoro Tomonori,Enzan Nobuyuki,Yamamoto Taishi,Sada Masashi,Deguchi Hiroko,Morimoto Sachio,Ide Tomomi,Tsutsui Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-46367-6.pdf

Reference51 articles.

1. Barrett-Lee, P. J. et al. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Ann Oncol. 20, 816–827, https://doi.org/10.1093/annonc/mdn728 (2009).

2. Felker, G. M. et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 342, 1077–1084, https://doi.org/10.1056/NEJM200004133421502 (2000).

3. Kotamraju, S., Konorev, E. A., Joseph, J. & Kalyanaraman, B. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem. 275, 33585–33592, https://doi.org/10.1074/jbc.M003890200 (2000).

4. Wang, L., Ma, W., Markovich, R., Chen, J. W. & Wang, P. H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res. 83, 516–522 (1998).

5. Zhang, S. et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 18, 1639–1642, https://doi.org/10.1038/nm.2919 (2012).

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity;European Journal of Pharmaceutical Sciences;2024-09

2. Dibenzazepine, a γ-Secretase Enzyme Inhibitor, Protects Against Doxorubicin-Induced Cardiotoxicity by Suppressing NF-κB, iNOS, and Hes1/Hey1 Expression;Inflammation;2024-07-30

3. Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review;Current Treatment Options in Oncology;2024-07-27

4. Doxorubicin-induced cardiotoxicity and risk factors;IJC Heart & Vasculature;2024-02

5. Mitochondrial Responses to Sublethal Doxorubicin in H9c2 Cardiomyocytes: The Role of Phosphorylated CaMKII;Yonago Acta Medica;2024